Tag: biotech
-
Experimental Immunotherapy Could Be a Universal Cancer Cure
What this new immunotherapy claims to do In a wave of promising early findings, researchers in the United States report an experimental immunotherapy that could treat multiple cancers, including solid tumors and hematologic malignancies. In initial-stage studies, scientists engineered immune cells to recognize common features shared by many cancers, while incorporating safety mechanisms to protect…
-
Promising Huntington’s disease gene therapy slows progression, but questions remain
What the early results show News from a European biotech company on a new gene therapy has sparked guarded optimism in the Huntington’s disease community. The approach, delivered during brain surgery, targets the genetic error that drives the condition. In a small, preliminary trial involving roughly 30 participants, the highest dose of the treatment appeared…
-
Huntington’s Disease Gene Therapy: Promise Amid Unanswered Questions
New Hope in Huntington’s Disease Gene Therapy A European biotech company, uniQure, has released preliminary results from an experimental gene therapy (AMT-130) aimed at Huntington’s disease. The data suggest the therapy could slow disease progression by about 75% over three years in patients receiving the highest dose. The treatment is delivered directly into the brain…